Drugs that contain Dolutegravir Sodium

1. List of Tivicay drug patents

TIVICAY's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8129385 VIIV HLTHCARE Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness
Oct, 2027

(4 years from now)

US9242986 VIIV HLTHCARE Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
Dec, 2029

(6 years from now)

Market Authorisation Date: 12 August, 2013

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of TIVICAY before it's patent expiration?
More Information on Dosage

TIVICAY family patents

33

United States

15

Japan

13

European Union

9

Spain

7

Korea, Republic of

6

Hungary

6

Slovenia

6

Denmark

5

Portugal

5

Norway

5

Mexico

5

Hong Kong

5

Poland

4

Lithuania

4

Canada

4

Australia

3

Brazil

3

China

3

Taiwan, Province of China

3

Cyprus

3

Israel

2

Russia

2

Morocco

2

EA

2

South Africa

2

Luxembourg

2

Netherlands

1

Singapore

1

New Zealand

1

Philippines

1

Austria

1

Ukraine

1

Viet Nam

2. List of Tivicay Pd drug patents

TIVICAY PD's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8129385 VIIV HLTHCARE Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness
Oct, 2027

(4 years from now)

US9242986 VIIV HLTHCARE Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
Dec, 2029

(6 years from now)

Market Authorisation Date: 12 June, 2020

Treatment: NA

Dosage: TABLET, FOR SUSPENSION;ORAL

How can I launch a generic of TIVICAY PD before it's patent expiration?
More Information on Dosage

TIVICAY PD family patents

33

United States

15

Japan

13

European Union

9

Spain

7

Korea, Republic of

6

Hungary

6

Slovenia

6

Denmark

5

Portugal

5

Norway

5

Mexico

5

Hong Kong

5

Poland

4

Lithuania

4

Canada

4

Australia

3

Brazil

3

China

3

Taiwan, Province of China

3

Cyprus

3

Israel

2

Russia

2

Morocco

2

EA

2

South Africa

2

Luxembourg

2

Netherlands

1

Singapore

1

New Zealand

1

Philippines

1

Austria

1

Ukraine

1

Viet Nam

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic